Skip to content

Solid Biosciences Inc.

SLDB

CIK 0001707502

← back to feed
Revenue (TTM)
$0
−40.6% YoY Q1 May 2026
Net Income (TTM)
−$74.82M
−434.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.84
+35.0% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$133.21M
Q1 May 2026
Cash
$297.1M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
98.45M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings